REALIZE: CVL-865 to Treat EpilepsyResearch Question:
What is the efficacy of CVL-865 as adjunctive therapy compared with placebo in subjects
with focal onset seizures?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
This placebo-controlled, double-blind trial is designed to assess the efficacy, safety
and tolerability profile of CVL-865 as adjunctive treatment in subjects with drug-resistant
focal onset seizures. Subjects will be randomized into one of three arms in a 1:1:1
ratio: one of two formulations of the study drug and placebo.
Study Reference #: 4612
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Cate Concannon
Phone: (585) 275-0404
Additional Study Details
Eligibility: Ages 18 - 75 (inclusive) with a diagnosis of focal epilepsy.
Number of Visits:
6 to 10
Learn More About These Conditions
More information about Epilepsy
Trial Not Found
The study you are looking for is not active at this time.
Return to Search